no09

Information about no09

Published on March 21, 2008

Author: Ubert

Source: authorstream.com

Content

Slide1:  Leprosy and the Eye Teaching Set © 1999, revised February 2005 International Centre for Eye Health, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. Supported by CBM International, Sight Savers International, Tijssen Foundation. INTERNATIONAL CENTRE FOR EYE HEALTH Section 1: Introduction 1. What is leprosy and how is leprosy transmitted?:  Section 1: Introduction 1. What is leprosy and how is leprosy transmitted? Section 2: Leprosy around the world 2. Leprosy around the world:  Section 2: Leprosy around the world 2. Leprosy around the world Section 3: Clinical presentations 3. Clinical presentations :  Section 3: Clinical presentations 3. Clinical presentations Section 3: Clinical presentations 4. Paucibacillary Leprosy and Multibacillary Leprosy :  Section 3: Clinical presentations 4. Paucibacillary Leprosy and Multibacillary Leprosy Section 4: Skin smear in diagnosis 5. Skin smear in diagnosis :  Section 4: Skin smear in diagnosis 5. Skin smear in diagnosis Section 5: Multidrug therapy 6. Multidrug therapy:  Section 5: Multidrug therapy 6. Multidrug therapy Leprosy treatment regimens Paucibacillary: single skin lesion: 600mg rifampicin single dose 400mg ofloxacin single dose 100mg minocycline single dose Paucibacillary: 2-5 skin lesions: 100mg DDS (dapsone) once daily 600mg rifampicin once per month (supervised monthly: 6 doses to be completed) Multibacillary leprosy: 100mg DDS (dapsone) once daily. 50mg clofazimine (lamprene), once daily. 600mg rifampicin once per month 300mg clofazimine once per month, (supervised monthly: 12 doses to be completed) Section 6: Leprosy 7. Reactions (type 1 and type 2): massive infiltration with M. leprae and secondary atrophy:  Section 6: Leprosy 7. Reactions (type 1 and type 2): massive infiltration with M. leprae and secondary atrophy Leprosy Top left: Type1 Reversal reaction Top right: Type 2 ENL Reaction Bottom left: Massive infiltration with M. leprae Bottom right: Secondary atrophy Section 7: Treatment of leprosy 8. (1) reactions (2) massive infiltration with M. leprae and secondary atrophy:  Section 7: Treatment of leprosy 8. (1) reactions (2) massive infiltration with M. leprae and secondary atrophy Slide10:  Section 8: Eye complications 9: Eye complications Leprosy: Potentially Blinding Lesions Lagophthalmos (whole spectrum) Corneal hypoaesthesia (whole spectrum) Acute iritis and scleritis (MB leprosy) Chronic iritis and iris atrophy (MB leprosy) Cataract (whole spectrum) Slide11:  Section 8: Eye complications 10: Lagophthalmos Slide12:  Section 8: Eye complications 11. Treatment of lagophthalmos Duration of lagophthalmos ≤ 6 months: prednisolone 40mg/day slowly reducing over 12 weeks Duration of lagophthalmos > 6 months with eyelid gap < 6 mm: Conservative treatment, e.g sunglasses, 'think blink‘ 3. Duration of lagophthalmos > 6 months with eyelid gap  6 mm: eyelid surgery Slide13:  Section 8: Eye complications 12. Lateral Tarsorrhaphy for Lagophthalmos Slide14:  Section 8: Eye complications 13. Exposure Keratitis Slide15:  Section 8: Eye complications 14. Corneal Hypoaesthesia Slide16:  Section 8: Eye complications 15. Type 2 Reaction: Acute Iritis Slide17:  Section 8: Eye complications 16. Type 2 Reaction: Acute Episcleritis and Scleritis Slide18:  Section 8: Eye complications 17. Massive Bacillary Infiltration: Peri-Orbital Complications Slide19:  Section 8: Eye complications 18. Massive Bacillary Infiltration: Ocular Infiltration Slide20:  Section 8: Eye complications 19. Massive Bacillary Infiltration: Ocular Atrophic Changes Slide21:  Section 9: Leprosy and cataract 20. Leprosy and cataract Slide22:  Section 10: Examination of the eyes in leprosy 21. Examination of the eyes in leprosy Slide23:  Section 10: Examination of the eyes in leprosy 22. Visual Disability Grading Disability Grade 0: No eye problems due to leprosy; no evidence of visual loss Disability Grade 2: Eye problems due to leprosy present; (1) severe visual impairment (vision worse than 6/60; unable to count fingers at six metres); (2) lagophthalmos; Slide24:  Section 11: Patients most at risk of severe eye complications and blindness 23. Patients most at risk of severe eye complications and blindness Slide25:  Section 12 24. Prevention of blindness due to leprosy Leprosy: Prevention of Blindness Early diagnosis of leprosy: MDT treatment Early recognition of reactions: effective treatment with systemic steroids Regular eye examination: treatment of any complications Lagophthalmos surgery: all patients with a eyelid gap of ≥ 6 mm Lens extraction: leprosy patients with blinding cataract

Related presentations


Other presentations created by Ubert

Deltas
09. 01. 2008
0 views

Deltas

Perfumes
10. 01. 2008
0 views

Perfumes

Powerpoint Programas Co 12
11. 01. 2008
0 views

Powerpoint Programas Co 12

Religion and Everyday Life
14. 01. 2008
0 views

Religion and Everyday Life

English Monolingual Lexicography
14. 01. 2008
0 views

English Monolingual Lexicography

AquaticBiome APES
15. 01. 2008
0 views

AquaticBiome APES

ww5
15. 01. 2008
0 views

ww5

geos112gw
16. 01. 2008
0 views

geos112gw

session 37 Adrienne Jeffries
17. 01. 2008
0 views

session 37 Adrienne Jeffries

Calibration Management
18. 01. 2008
0 views

Calibration Management

Orbital Mechanics Overview 2
11. 01. 2008
0 views

Orbital Mechanics Overview 2

PROCUREMENT WORKSHOP MRanger
22. 01. 2008
0 views

PROCUREMENT WORKSHOP MRanger

Life of a slave 2
24. 01. 2008
0 views

Life of a slave 2

Starting a Voices group final
04. 02. 2008
0 views

Starting a Voices group final

application programming
04. 02. 2008
0 views

application programming

Top 10 final
22. 01. 2008
0 views

Top 10 final

2006 opslesson11a
28. 01. 2008
0 views

2006 opslesson11a

amoussou
29. 01. 2008
0 views

amoussou

StarryM 0703
24. 01. 2008
0 views

StarryM 0703

2007524105753299
15. 01. 2008
0 views

2007524105753299

Renal pathology for web
25. 02. 2008
0 views

Renal pathology for web

Chapter 10 Spirit of Baroque
26. 02. 2008
0 views

Chapter 10 Spirit of Baroque

Scharf Sleep September21 1st
28. 02. 2008
0 views

Scharf Sleep September21 1st

earlyeuropeanmedicine
11. 03. 2008
0 views

earlyeuropeanmedicine

Hansford Ucam Ozone
20. 02. 2008
0 views

Hansford Ucam Ozone

AAS207Excite
19. 03. 2008
0 views

AAS207Excite

aetna presentation
15. 01. 2008
0 views

aetna presentation

Desert
03. 04. 2008
0 views

Desert

Session 6 Malaysia MMU
08. 04. 2008
0 views

Session 6 Malaysia MMU

3490 Class 8
16. 04. 2008
0 views

3490 Class 8

2007041716325228351
24. 04. 2008
0 views

2007041716325228351

Cassini Huygens
09. 01. 2008
0 views

Cassini Huygens

ngupdate 2008
08. 05. 2008
0 views

ngupdate 2008

1 20080331132330
02. 05. 2008
0 views

1 20080331132330

Wedding Gown Ideas
05. 02. 2008
0 views

Wedding Gown Ideas

DeepImpact
09. 01. 2008
0 views

DeepImpact

T1Wk10 Wave Properties
14. 02. 2008
0 views

T1Wk10 Wave Properties

denardi sab06 srw
13. 01. 2008
0 views

denardi sab06 srw

BusinessLaw
04. 02. 2008
0 views

BusinessLaw